M. DI CROHN: RISANKIZUMAB DOPO FAILURE DI USTEKINUMAB. UNA LETTERA DA “GASTROENTEROLOGY” (FREE)
Effectiveness of Risankizumab After Ustekinumab Failure in Crohn’s Disease: A Multicenter Retrospective Cohort Study SHIVA MEHTA-DHAND et al. Dysregulation of…

